ロード中...
Bone Marrow Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo
The use of bone marrow derived mesenchymal stromal cells (BMSC) in the treatment of alloimmune and autoimmune conditions has generated much interest, yet an understanding of the therapeutic mechanism remains elusive. We therefore explored immune modulation by a clinical-grade BMSC product in a model...
保存先:
| 出版年: | Stem Cells |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4376558/ https://ncbi.nlm.nih.gov/pubmed/25532725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.1934 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|